Rochester, New York 1/7/2010 4:05:00 AM
News / Business

CIGNA Corporation (NYSE:CI) to Present at JP Morgan Healthcare Conference January 13

CIGNA Corporation (NYSE:CI) will speak at the 28th Annual JP Morgan Healthcare Conference on Wednesday, January 13.  Speaking will be CIGNA President and Chief Executive Officer David Cordani.  The company is scheduled to begin its presentation at 8:30 am PT that morning. 

 

Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.

 

Interested parties may listen to a webcast of the event online at http://www.cigna.com/.  The webcast will be on the Event Calendar page of the Investors section.  Listeners are encouraged to log on fifteen minutes prior to the scheduled start of the event to allow enough time to download and install any necessary audio software.

 

CIGNA Corporation (CIGNA) is an investor-owned health service organization in the United States. The Company’s subsidiaries are providers of healthcare and related benefits, the majority of which are offered through the workplace, including healthcare products and services; group disability, life and accident insurance, and workers’ compensation case management and related services. CIGNA’s revenues are derived principally from premiums, fees, mail order pharmacy, other revenues and investment income. The Company operates in five business segments: HealthCare; Disability and Life; International; Run-off Reinsurance, and Other Operations.

 

Follow us on Twitter: http://www.twitter.com/pennystockspro

 

Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

 

About Us

 

Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer.